German blood pressure initiative to flush out hidden sufferers?
This article was originally published in Clinica
Executive Summary
German doctors and pharmacists have agreed on new readings for high blood pressure in a bid to encourage more people to check their levels and seek treatment if necessary. There are some 30 million individuals with high blood pressure in Germany, but only 15 million are aware of it. The German population is 80 million. German High Blood Pressure League chairman Prof Joachim Hoyer said: “The hidden population of sufferers especially will benefit from this close co-operation between doctors and pharmacists.” The German pharmacists’ union (ABDA) agreed. High blood pressure is, as before, 140/90 mm (millimetres of mercury). Patients with readings above this should see a doctor with no unreasonable delay. What's new is that this now also applies for diabetics and renal/heart disease patients with a lower reading of 130/85. And a reading of 160/100 means the patient should seek medical attention immediately. The broader awareness of the need to control high blood pressure will have positive spin-offs for certain OEM manufacturers, but, more crucially, will benefit patients and potentially reduce longer-term costs to the German healthcare system.
You may also be interested in...
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.